ACCD Accolade Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ACCD

Price (delayed)

$4.08

Market cap

$326.43M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.15

Enterprise value

$378.32M

Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Accolade helps millions of people and their employers navigate the complexities of the ...

Highlights
The EPS has grown by 46% YoY and by 14% from the previous quarter
The company's net income rose by 43% YoY and by 11% QoQ
Accolade's quick ratio has decreased by 10% YoY but it has increased by 7% from the previous quarter
The company's equity fell by 4.2% YoY and by 2.3% QoQ
Sector: Healthcare
Industry: Health Information Services
Website: http://www.accolade.com
Peers: PRVA

Key stats

What are the main financial stats of ACCD
Market
Shares outstanding
80.01M
Market cap
$326.43M
Enterprise value
$378.32M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.73
Price to sales (P/S)
0.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.88
Earnings
Revenue
$431.53M
EBIT
-$92.54M
EBITDA
-$48.62M
Free cash flow
-$15.06M
Per share
EPS
-$1.15
Free cash flow per share
-$0.19
Book value per share
$5.55
Revenue per share
$5.52
TBVPS
$4.26
Balance sheet
Total assets
$767.37M
Total liabilities
$332.1M
Debt
$240.6M
Equity
$435.27M
Working capital
$176.82M
Liquidity
Debt to equity
0.55
Current ratio
2.8
Quick ratio
2.62
Net debt/EBITDA
-1.07
Margins
EBITDA margin
-11.3%
Gross margin
47.5%
Net margin
-20.6%
Operating margin
-24.1%
Efficiency
Return on assets
-11.1%
Return on equity
-20.3%
Return on invested capital
-33.3%
Return on capital employed
-13.8%
Return on sales
-21.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ACCD stock price

How has the Accolade stock price performed over time
Intraday
5.97%
1 week
18.26%
1 month
-33.44%
1 year
-71.17%
YTD
-66.03%
QTD
13.97%

Financial performance

How have Accolade's revenue and profit performed over time
Revenue
$431.53M
Gross profit
$204.89M
Operating income
-$103.87M
Net income
-$88.99M
Gross margin
47.5%
Net margin
-20.6%
The net margin has surged by 51% year-on-year and by 15% since the previous quarter
The company's operating margin rose by 43% YoY and by 13% QoQ
The company's net income rose by 43% YoY and by 11% QoQ
The operating income has increased by 34% YoY and by 9% QoQ

Growth

What is Accolade's growth rate over time

Valuation

What is Accolade stock price valuation
P/E
N/A
P/B
0.73
P/S
0.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.88
The EPS has grown by 46% YoY and by 14% from the previous quarter
The stock's price to book (P/B) is 78% less than its 5-year quarterly average of 3.1 and 59% less than its last 4 quarters average of 1.7
The company's equity fell by 4.2% YoY and by 2.3% QoQ
ACCD's P/S is 87% lower than its 5-year quarterly average of 5.5 and 63% lower than its last 4 quarters average of 1.9
The revenue is up by 16% year-on-year and by 4.2% since the previous quarter

Efficiency

How efficient is Accolade business performance
The ROS has grown by 49% YoY and by 15% from the previous quarter
Accolade's ROE has increased by 37% YoY and by 10% from the previous quarter
The company's return on invested capital rose by 36% YoY and by 10% QoQ
ACCD's return on assets is up by 35% year-on-year and by 8% since the previous quarter

Dividends

What is ACCD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACCD.

Financial health

How did Accolade financials performed over time
The total assets is 131% more than the total liabilities
The company's total liabilities fell by 21% YoY and by 3.1% QoQ
The total assets has contracted by 12% YoY and by 2.6% from the previous quarter
The debt is 45% smaller than the equity
The debt has declined by 24% year-on-year
ACCD's debt to equity is down by 20% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.